Scinovex
articleTop 10% cited

HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment

Breast Cancer Research and Treatment · 2009 · Vol. 122(1) · pp. 35–43
Britta WeigeltAlvin LoCatherine C. ParkJoe W. GrayMina J. Bissell
HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchCellular Mechanics and InteractionsLapatinibPertuzumabTrastuzumabCancer researchSKBR3Tumor microenvironmentSignal transductionPI3K/AKT/mTOR pathwayCell biologyCell signaling

MeSH terms

TrastuzumabLapatinibAntibodies, MonoclonalAntineoplastic AgentsCell DivisionCell SurvivalEnzyme ActivationExtracellular MatrixFemaleGelsHumansLamininNeoplasm ProteinsQuinazolinesSignal Transduction
Citations
332
FWCI
8.12
field-weighted impact
References
39
Percentile
98%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.